- Home
- ALNY vs VMC Comparison
ALNY vs VMC Comparison
Compare ALNY & VMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALNY
- VMC
- Stock Information
- Founded
- ALNY 2002
- VMC 1909
- Country
- ALNY United States
- VMC United States
- Employees
- ALNY N/A
- VMC N/A
- Industry
- ALNY Biotechnology: Pharmaceutical Preparations
- VMC Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- Sector
- ALNY Health Care
- VMC Industrials
- Exchange
- ALNY Nasdaq
- VMC Nasdaq
- Market Cap
- ALNY 35.0B
- VMC 31.8B
- IPO Year
- ALNY 2004
- VMC N/A
- Fundamental
- Price
- ALNY $251.15
- VMC $269.76
- Analyst Decision
- ALNY Strong Buy
- VMC Buy
- Analyst Count
- ALNY 25
- VMC 12
- Target Price
- ALNY $324.54
- VMC $295.64
- AVG Volume (30 Days)
- ALNY 972.8K
- VMC 918.4K
- Earning Date
- ALNY 05-01-2025
- VMC 04-30-2025
- Dividend Yield
- ALNY N/A
- VMC 0.73%
- EPS Growth
- ALNY N/A
- VMC 3.11
- EPS
- ALNY N/A
- VMC 7.06
- Revenue
- ALNY $2,348,099,000.00
- VMC $7,506,600,000.00
- Revenue This Year
- ALNY $31.88
- VMC $12.03
- Revenue Next Year
- ALNY $25.06
- VMC $7.36
- P/E Ratio
- ALNY N/A
- VMC $38.18
- Revenue Growth
- ALNY 17.21
- VMC N/A
- 52 Week Low
- ALNY $144.73
- VMC $215.08
- 52 Week High
- ALNY $304.39
- VMC $298.31
- Technical
- Relative Strength Index (RSI)
- ALNY 48.55
- VMC 68.03
- Support Level
- ALNY $245.96
- VMC $264.87
- Resistance Level
- ALNY $277.85
- VMC $271.08
- Average True Range (ATR)
- ALNY 10.60
- VMC 5.74
- MACD
- ALNY 1.41
- VMC 2.07
- Stochastic Oscillator
- ALNY 42.07
- VMC 93.38
About ALNY Alnylam Pharmaceuticals Inc.
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia. It also has several clinical programs across various therapeutic areas: genetic medicines; cardio-metabolic diseases; hepatic infectious diseases, and CNS/ocular diseases. Upfront fees from research partnerships have boosted Alnylam's cash levels, and the company stands to see additional milestones and royalties from drugs commercialized under collaboration partnerships.
About VMC Vulcan Materials Company (Holding Company)
Vulcan Materials is the United States' largest producer of construction aggregates (crushed stone, sand, and gravel). Its largest markets include Texas, California, Virginia, Tennessee, Georgia, Florida, North Carolina, and Alabama. In 2024, Vulcan sold 219.9 million tons of aggregates, 13.6 million tons of asphalt mix, and 3.6million cubic yards of ready-mix. As of Dec. 31, 2023, the company had nearly 16 billion tons of aggregates reserves.